Roth, Gaël S <br/><br/>
Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma.  [electronic resource] 

 -  Molecular cancer therapeutics  10 2017 
 - 2157-2165 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-16-0602-T  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminopyridines--administration & dosage<br/>Animals<br/>Apoptosis--drug effects<br/>Carcinoma, Hepatocellular--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Disease Models, Animal<br/>Humans<br/>Imidazoles--administration & dosage<br/>Liver Cirrhosis--drug therapy<br/>Liver Neoplasms--drug therapy<br/>Niacinamide--administration & dosage<br/>Oncogene Protein v-akt--antagonists & inhibitors<br/>Phenylurea Compounds--administration & dosage<br/>Rats<br/>Signal Transduction--drug effects<br/>Sorafenib